Condition: Esophageal Cancer · Sponsor: The Cleveland Clinic
The investigators propose to compare recurrence-free survival in patients having potentially curative (Stages 1-3) surgery for esophageal cancer who will be randomly assigned to propofol-based total intravenous anesthesia or sevoflurane-based balanced general anesthesia.
This description comes directly from the study's public registry record.
Daniel I Sessler, MD · 216-870-2620 · DS@CCF.org
Fabio Rodriquez Patarroyo, MD · (216) 444-9674 · Rodrigf3@ccf.org
Always discuss trial participation with your own doctor first.
| Shanhai Chest Hospital | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04513808